Genentech Articles
Stock Commentary - New York week to July 14, 2008
21 July 2008
Singapore reinforces position as a global site for pharma and biotech; output quadruples
30 June 2008
Seattle Gen achieves milestone in Genentech accord
30 June 2008
Genentech settles Cabilly patent case
16 June 2008
ASCO: oncologists rank Genentech "number one"
16 June 2008
Stock Commentary - New York week to June 2, 2008
9 June 2008
Takeda subsid appoints new president and CSO
2 June 2008
Daiichi Sankyo takes over U3 Pharma
26 May 2008
PDL's 1st-qtr 2008 net loss triples to $62M
26 May 2008
VEGF Trap-Eye enters Ph III testing
19 May 2008
Stock Commentary - New York week to May 5, 2008
12 May 2008
Rituxan misses Ph II/III endpoint in SLE
5 May 2008
Biogen Idec's 1st-qtr 2008 profit jumps 23%
5 May 2008
US court reduces Genentech damages
5 May 2008
Stock Commentary - New York week to April 21, 2008
28 April 2008
Stock Commentary - Europe - week to April 21, 2008
28 April 2008
Roche's Avastin fails to show overall survival
28 April 2008
Stock Commentary - New York week to April 14, 2008
21 April 2008
Sweden's BioInvent falls into loss
21 April 2008
Japan stock market week to March 17, 2008
24 March 2008
Genentech options Exelixis' MEK inhibitor
24 March 2008
Piramed's cancer drug starts clinical testing
24 March 2008
Xoma's 2007 loss falls 76% as sales soar 185%
24 March 2008
Abbott and Genentech sign Tarceva assay deal
17 March 2008
Wyeth halts Hedgehog agonist deal with Curis
17 March 2008
Japan stock market week to March 10, 2008
17 March 2008
Strong early data on Davanat plus 5-FU in CRC
10 March 2008
Stock Commentary - Europe - week to Feb 25, 2008
3 March 2008
Elderly urged to change lifestyle to battle AMD
3 March 2008
Stock Commentary - New York week to Feb 25, 2008
3 March 2008
Drug of benefit more than 3 hrs post stroke
3 March 2008
Biogen's 4th-qtr net income climbs 85%
14 February 2008
FDA advisors declare the agency's "science and mission are at risk"
11 February 2008
Roche pipeline includes several potential blockbusters likely to enter Ph III testing
11 February 2008
Stock Commentary - New York week to Jan 28, 2008
4 February 2008
Ipsen abandons EU NutropinAq application
4 February 2008
Patients on rituximab achieve ACR 20 response
4 February 2008
Tercica begins dosing in Ph II IGF-1 deficiency trial
4 February 2008
Stock Commentary - Europe - week to Jan 21, 2008
28 January 2008
BioInvent gets OK for BI-204 trial
21 January 2008
Seattle Genetics earns $4M Genentech milestone
14 January 2008
Altus regains ALTU-238 rights from Genentech
7 January 2008
Avastin shows good safety profile in Ph II breast cancer trial
24 December 2007
OSI's Tarceva to debut in Japan Dec 18
24 December 2007
Fourth Genmab/Roche Ab enters clinic in USA
17 December 2007
Stock Commentary - New York week to Dec 3, 2007
10 December 2007
ODAC
10 December 2007
Driven by Avastin, ovarian cancer market set to reach $1.6B by 2016
10 December 2007
NeoVista enrolls first patient in EU trial of AMD radiotherapy
3 December 2007
PDL's 3rd-qtr loss falls 9% despite charges
26 November 2007
Xoma posts $22M third quarter profit
19 November 2007
New biologicals are the stars of the 2007 ACR meeting
19 November 2007
Breast cancer market set to reach $2.9B in 2013, but still no cure
12 November 2007
Tarceva helps OSI reach $30M 3rd-qtr profit
12 November 2007
Headlines 25 years ago this week....
5 November 2007
Seattle's loss climbs 70% on trial costs
5 November 2007
Genentech's 3rd-qtr income climbs 21% with sales of $2.9B; but analysts question reliance on Avastin
22 October 2007
Genentech to curtail off-label Avastin use
22 October 2007
Stock Commentary - New York week to Oct 8, 2007
15 October 2007
Headlines 25 years ago this week....
15 October 2007
TaiMed Biologics to develop Genentech HIV drug
24 September 2007
US biogenerics mart to reach $2B by 2016
17 September 2007
Stock Commentary - New York week to Sept 10, 2007
17 September 2007
Erbitux meets Ph III NSCLC trial endpoints
17 September 2007
Biogen forecasts 2007 sales growth of 16-18%, and EPS to increase 20% a year to 2010
17 September 2007
USA's NIH updated asthma treatment guidelines welcomed by industry
10 September 2007
Seattle Genetics gets investor attention
3 September 2007
Regeneron gets $20M milestone from Bayer
20 August 2007
Bayer/Regeneron begin Ph III Trap-Eye study
13 August 2007
PDL BioPharma swings into 2nd-qtr profit
13 August 2007
Progress on Genentech's acquisition of Tanox
13 August 2007
ImmunoGen gets $5M milestone
6 August 2007
- Is failure to adopt business process management putting the pharma industry at risk?
- New Zealand declines Alexion's funding application for Solaris
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- Elan makes "transformational" acquisitions and a divestment
